Chromobox protein inhibitors and uses thereof
US-2025034126-A1 · Jan 30, 2025 · US
This page is not indexed by search engines while we improve data quality.
Bradner James E patents
Bradner James E is listed as an inventor on 79 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Bradner James E |
| Total patents | 79 |
| First publication | Apr 7, 2015 |
| Latest publication | Jan 30, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Compositions and methods for selective protein degradation
US-2024384007-A1 · Nov 21, 2024 · US
Compositions and methods for selective protein degradation
US-11999802-B2 · Jun 4, 2024 · US
Stabilized peptide-mediated targeted protein degradation
US-2024140999-A1 · May 2, 2024 · US
Mechanism of resistance to bet bromodomain inhibitors
US-11666580-B2 · Jun 6, 2023 · US
Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof
US-11617750-B2 · Apr 4, 2023 · US
Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors
US-11446309-B2 · Sep 20, 2022 · US
Acetamide thienotriazolodiazepines and uses thereof
US-11406645-B2 · Aug 9, 2022 · US
Bivalent bromodomain inhibitors and uses thereof
US-2022119416-A9 · Apr 21, 2022 · US
Cyano thienotriazolodiazepines and uses thereof
US-11306105-B2 · Apr 19, 2022 · US
Recent patents
Latest publications not already listed above.
EZH2 inhibitors and uses thereof
US-11236082-B2 · Feb 1, 2022 · US
Acetamide thienotriazolodiazepines and uses thereof
US-2021393647-A9 · Dec 23, 2021 · US
Bivalent bromodomain inhibitors and uses thereof
US-2021221826-A1 · Jul 22, 2021 · US
Cyano thienotriazolodiazepines and uses thereof
US-2021206779-A9 · Jul 8, 2021 · US
Combination therapy for cancer using bromodomain and extra-terminal (bet) protein inhibitors
US-2021100813-A1 · Apr 8, 2021 · US
Acetamide thienotriazolodiazepines and uses thereof
US-2021093644-A1 · Apr 1, 2021 · US
Bivalent bromodomain inhibitors and uses thereof
US-10913752-B2 · Feb 9, 2021 · US
Acetamide thienotriazolodiazepines and uses thereof
US-10881668-B2 · Jan 5, 2021 · US
Mechanism of resistance to bet bromodomain inhibitors
US-2020368248-A1 · Nov 26, 2020 · US
Stabilized peptide-mediated targeted protein degradation
US-2020354413-A1 · Nov 12, 2020 · US
Compositions and methods for selective protein degradation
US-2020339704-A1 · Oct 29, 2020 · US
Uses of diazepane derivatives
US-10793571-B2 · Oct 6, 2020 · US
Diaminopyrimidine benzenesulfone derivatives and uses thereof
US-10730860-B2 · Aug 4, 2020 · US
Cyano thienotriazolodiazepines and uses thereof
US-2020199150-A1 · Jun 25, 2020 · US
Method for preparing largazole analogs and uses thereof
US-10676504-B2 · Jun 9, 2020 · US
Bivalent bromodomain inhibitors and uses thereof
US-2020172553-A9 · Jun 4, 2020 · US
EZH2 inhibitors and uses thereof
US-10633371-B2 · Apr 28, 2020 · US
Ezh2 inhibitors and uses thereof
US-2020039968-A9 · Feb 6, 2020 · US
Reverse Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof
US-2020030325-A1 · Jan 30, 2020 · US
Synthesis and utility of new capgroup largazole analogs
US-10538534-B2 · Jan 21, 2020 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Dana Farber Cancer Inst Inc | 74 |
| Harvard College | 9 |
| Univ Colorado State Res Found | 6 |
| Univ Notre Dame Du Lac | 5 |
| Novartis Ag | 3 |
Top CPC classifications
Most common classification codes across this inventor's patents.